Biological activation of N(G)-nitro-D-arginine by kidney homogenate

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 356, Issue 4, 1997, Pages 495-499

  Cheng, Xing ^a   Wang, Yong Xiang ^a   Pang, Catherine C Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Arginine; Endothelium dependent relaxation; Metabolic conversion; N(G) nitro D arginine (D NNA); N(G) nitro L arginine (L NNA); Nitric oxide (NO); Nitric oxide synthase

Indexed keywords

ACETYLCHOLINE; ARGININE; N(G) NITRO DEXTRO ARGININE; PHENYLEPHRINE;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; KIDNEY HOMOGENATE; NONHUMAN; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA; ARGININE; ENDOTHELIUM, VASCULAR; KIDNEY; LIVER; LUNG; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITROARGININE; RATS; RATS, WISTAR; STEREOISOMERISM;

EID: 0030867005     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005082     Document Type: Article

References (29)

1. Ariens, EJ (1993) Nonchiral, homochiral and composite chiral drugs. Trends Pharmacol Sci 14:68-75
2. Baillie TA, Adams WJ, Kaiser DG, Olanoff LS, Halstead GW, Harpootlian H, Van Giessen GJ (1989) Mechanistic studies of the metabolic chiral inversion of (R)-ibuprofen in humans. J Pharmacol Exp Ther 249:517-523
3. Caldwell J, Hutt AJ, Fournel-Gigleux S (1988) The metabolic chiral inversion and dispositional enantioselectivity of the 2-aryl-propionic acids and their biological consequences. Biochem Pharmacol 37:105-114
4. Drummond L, Caldwell J, Wilson HK (1990) The stereoselectivity of 1,2-phenylethanediol and mandelic acid metabolism and disposition in the rat. Xenobiotica 20:159-168
5. G-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol 101:625-631
6. G-nitro-arginine. Br J Pharmacol 102:565-566
7. Hutt AJ, Caldwell J (1983) The metabolic chiral inversion of 2-arylpropionic acids - a novel route with pharmacological consequences. J Pharmac Pharmacol 35:693-704
8. Ishii K, Chang B, Kerwin JF Jr, Huang Z-J, Murad F (1990) N-ω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol 176:219-223
9. Knihinicki RD, Day RO, Williams KM (1991) Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs. II. Racemization and hydrolysis of (R)- and (S)-ibuprofen-CoA thioesters. Biochem Pharmacol 42:1905-1911
10. Knihinicki RD, Williams KM, Day RO (1989) Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs. I. In vitro studies of ibuprofen and flurbiprofen. Biochem Pharmacol 38:4389-4395
11. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142
12. G-nitro-L-arginine (N5-[imino (nitro-amino) methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn-Schmiedeberg's Arch Pharmacol 341:143-147
13. Palmer RMJ, Rees DD, Ashton DS, Moncada S (1988) L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 153:1251-1256
14. Rees DD, Palmer RMJ, Moncada S (1989a) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 86:3375-3378
15. Rees DD, Palmer RMJ, Hodson HF, Moncada S (1989b) A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 96:418-424
16. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S (1990) Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101:746-752
17. Raszkiewicz JL, Linville DG, Kerwin JF Jr, Wagenaar F, Arneric SP (1992) Nitric oxide synthase is critical in mediating basal forebrain regulation of cortical cerebral circulation. J Neurosci Res 33:129-135
18. Reichel C, Bang H, Brune K, Geisslinger G, et al (1995) 2-Aryl-propionyl-CoA epimerase: partial peptide sequences and tissue localization. Biochem Pharmacol 50:1803-1806
19. Sanins SM, Adams WJ, Kaiser DG, Halstead GW, Hosley J, Barnes H, Baillie TA (1991) Mechanistic studies on the metabolic chiral inversion of R-ibuprofen in the rat. Drug Metab Dispos 19:405-410
20. Testa B, Carrupt PA, Gal J (1993) The so-called "interconversion" of stereoisomeric drugs: an attempt at clarification. Chirality 5:105-111
21. Walker J, Barrett J (1991) Pyridoxal 5′-phosphate dependent enzymes in the nematode Nippostrongylus brasiliensis. Int J Parasitol 21:641-649
22. G-nitro-L-arginine in pentobarbital-anesthetized rats. Life Sci 47:2217-2224
23. G-nitro-L-arginine on blood pressure in pentobarbital-anaesthetized rats. Pharmacology (Life Sci Adv) 9:723-728
24. G-nitro-arginine in conscious rats are antagonized by L- but not D-arginine. Eur J Pharmacol 200:77-81
25. G-nitro-arginine methyl ester in vitro and in vivo. J Pharmacol Exp Ther 267:1091-1090
26. G-nitro-arginine on endothelium-dependent relaxation of rat aorta. J Pharmacol Exp Ther 265:112-119
27. Yorifuji T (1971) Arginine racemase of Pseudomonas graveolens. II. Racemization and transamination of ornithine catalyzed by arginine racemase. J Biol Chem 246:5093-5101
28. Yoshida H, Kohno Y, Endo H, Yamaguchi J, et al (1997) Mechanistic studies on metabolic chiral inversion of 4-(4-methylphenyl)-2-methylthiomethyl-4-oxobutanoic acid (KE-748), an active metabolite of the new anti-rheumatic agent 2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298), in rat. Biochem Pharmacol 53:179-87
29. Zhang K, Tang C, Rashed M, Cui D, et al (1994) Metabolic chiral inversion of stiripentol in the rat. I. Mechanistic studies. Drug Metab Disp 22:544-553